V. Barone, O. Massa, E. Intravaia, A. Bracco, D. Martino et al., Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families, J Med Genet, vol.36, pp.115-118, 1999.

A. Brandt, L. Schleithoff, K. Jurkat-rott, W. Klingler, C. Baur et al., Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test, Human Molecular Genetics, vol.8, issue.11, pp.2055-2062, 1999.
DOI : 10.1093/hmg/8.11.2055

B. Britt and W. Kalow, Malignant hyperthermia: A statistical review, Canadian Anaesthetists??? Society Journal, vol.277, issue.4, pp.293-315, 1970.
DOI : 10.1007/BF03004694

R. Brown, A. Pollock, K. Couchman, M. Hodges, D. Hutchinson et al., A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree, Human Molecular Genetics, vol.9, issue.10, pp.1515-1524, 2000.
DOI : 10.1093/hmg/9.10.1515

S. Chen, J. Airey, and D. Maclennan, Positioning of major tryptic fragments in the Ca 21 release channel (ryanodine receptor) resulting from partial digestion of rabbit skeletal muscle sarcoplasmic reticulum, J Biol Chem, vol.268, pp.22642-22649, 1993.

S. Chen, P. Leong, J. Imredy, C. Bartlett, L. Zhang et al., Single-channel properties of the recombinant skeletal muscle Ca 21 release channel (ryanodine receptor), 1997.

R. Cottingham, . Jr, R. Idury, and A. Schäffer, Faster sequential genetic linkage computations, Am J Hum Genet, vol.53, pp.252-263, 1993.

M. Denborough and R. Lovell, Anaesthetic deaths in a family, Lancet, vol.2, p.45, 1960.

G. Du, B. Sandhu, V. Khanna, X. Guo, and D. Maclennan, Topology of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum (RyR1), Proceedings of the National Academy of Sciences, vol.99, issue.26, pp.16725-16730, 2002.
DOI : 10.1073/pnas.012688999

E. Malignant and H. Group, A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility, Br J Anaesth, vol.56, pp.1267-1269, 1984.

L. Galli, A. Orrico, S. Cozzolino, V. Pietrini, V. Tegazzin et al., Mutations in the RYR1 gene in Italian patients at risk for Malignant Hyperthermia: evidence for a cluster of novel mutations in the C-terminal region, Cell Calcium, vol.32, issue.3, pp.143-151, 2002.
DOI : 10.1016/S0143-4160(02)00138-0

E. Gillard, K. Otsu, J. Fujii, V. Khanna, D. Leon et al., A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia, Genomics, vol.11, issue.3, pp.751-755, 1991.
DOI : 10.1016/0888-7543(91)90084-R

E. Gillard, K. Otsu, J. Fujii, C. Duff, D. Leon et al., Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia, Genomics, vol.13, issue.4, pp.1247-1254, 1992.
DOI : 10.1016/0888-7543(92)90042-Q

T. Girard, A. Urwyler, K. Censier, C. Mueller, F. Zorzato et al., Genotype-phenotype comparison of the Swiss malignant hyperthermia population, Human Mutation, vol.18, issue.4, pp.357-358, 2001.
DOI : 10.1002/humu.1203

T. Girard, S. Treves, . Voronkov, M. Siegemund, and A. Urwyler, Molecular genetic testing to diagnose malignant hyperthermia susceptibility, Journal of Clinical Anesthesia, vol.20, issue.3, pp.1076-1080, 2004.
DOI : 10.1016/j.jclinane.2007.12.011

S. Guis, D. Figarella-branger, N. Monnier, D. Bendahan, G. Kozak-ribbens et al., Multiminicore Disease in a Family Susceptible to Malignant Hyperthermia, Archives of Neurology, vol.61, issue.1, pp.106-113, 2004.
DOI : 10.1001/archneur.61.1.106

H. Jungbluth, C. Muller, B. Halliger-keller, M. Brockington, S. Brown et al., Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores, Neurology, vol.59, issue.2, pp.284-287, 2002.
DOI : 10.1212/WNL.59.2.284

K. Keating, K. Quane, B. Manning, M. Lehane, E. Hartnung et al., Detection of a novel RYR1 mutation in four malignant hyperthermia pedigrees, Human Molecular Genetics, vol.3, issue.10, pp.1855-1858, 1994.
DOI : 10.1093/hmg/3.10.1855

K. Keating, L. Giblin, P. Lynch, K. Quane, M. Lehane et al., Detection of a novel mutation in the ryanodine receptor gene in an Irish malignant hyperthermia pedigree: correlation of the IVCT response with the affected and unaffected haplotypes., Journal of Medical Genetics, vol.34, issue.4, pp.291-296, 1997.
DOI : 10.1136/jmg.34.4.291

N. Kraev, J. Loke, A. Kraev, and D. Maclennan, Protocol for the Sequence Analysis of Ryanodine Receptor Subtype 1 Gene Transcripts from Human Leukocytes, Anesthesiology, vol.99, issue.2, pp.289-296, 2003.
DOI : 10.1097/00000542-200308000-00010

J. Loke, N. Kraev, P. Sharma, G. Du, L. Patel et al., Detection of a Novel Ryanodine Receptor Subtype 1 Mutation (R328W) in a Malignant Hyperthermia Family by Sequencing of a Leukocyte Transcript, Anesthesiology, vol.99, issue.2, pp.297-302, 2003.
DOI : 10.1097/00000542-200308000-00011

P. Lynch, R. Krivosic-horber, H. Reyford, N. Monnier, K. Quane et al., Identification of Heterozygous and Homozygous Individuals with the Novel RYR1 Mutation Cys35Arg in a Large Kindred, Anesthesiology, vol.86, issue.3, pp.620-626, 1997.
DOI : 10.1097/00000542-199703000-00014

P. Lynch, J. Tong, M. Lehane, A. Mallet, L. Giblin et al., A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease, Proceedings of the National Academy of Sciences, vol.96, issue.7, pp.4164-4169, 1999.
DOI : 10.1073/pnas.96.7.4164

B. Manning, K. Quane, H. Ording, A. Urwyler, V. Tegazzin et al., Identification of Novel Mutations in the Ryanodine-Receptor Gene (RYR1) in Malignant Hyperthermia: Genotype-Phenotype Correlation, The American Journal of Human Genetics, vol.62, issue.3, pp.599-609, 1998.
DOI : 10.1086/301748

T. Mccarthy, K. Quane, and P. Lynch, Ryanodine receptor mutations in malignant hyperthermia and central core disease, Human Mutation, vol.5, issue.5, pp.410-417, 2000.
DOI : 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D

N. Monnier, V. Procaccio, P. Stieglitz, and J. Lunardi, Malignant-Hyperthermia Susceptibility Is Associated with a Mutation of the a1-Subunit of the Human Dihydropyridine-Sensitive L-Type Voltage-Dependent Calcium-Channel Receptor in Skeletal Muscle, The American Journal of Human Genetics, vol.60, issue.6, pp.1316-1325, 1997.
DOI : 10.1086/515454

N. Monnier, N. Romero, J. Lerale, Y. Nivoche, D. Qi et al., An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor, Human Molecular Genetics, vol.9, issue.18, pp.2599-2608, 2000.
DOI : 10.1093/hmg/9.18.2599

N. Monnier, N. Romero, J. Lerale, P. Landrieu, Y. Nivoche et al., Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor, Human Molecular Genetics, vol.10, issue.22, pp.2581-2592, 2001.
DOI : 10.1093/hmg/10.22.2581

N. Monnier, R. Krivosic-horber, J. Payen, G. Kozak-ribbens, Y. Nivoche et al., Presence of Two Different Genetic Traits in Malignant Hyperthermia Families, Anesthesiology, vol.97, issue.5, pp.1067-1074, 2002.
DOI : 10.1097/00000542-200211000-00007

N. Monnier, A. Ferreiro, I. Marty, A. Labarre-vila, P. Mezin et al., A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with MmD congenital myopathy with ophthalmoplegia, Hum Mol Genet, vol.12, pp.1-8, 2003.

H. Ording, The Incidence of Malignant Hyperthermia in Denmark, Anesth Analg, vol.64, pp.700-704, 1985.
DOI : 10.1007/978-4-431-68346-9_2

H. Ording, V. Brancadoro, S. Cozzolino, F. Ellis, V. Glauber et al., In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and unrelated low-risk subjects, Acta Anaesthesiologica Scandinavica, vol.33, issue.8, pp.955-966, 1997.
DOI : 10.1111/j.1399-6576.1997.tb04820.x

H. Oyamada, K. Oguchi, N. Saitoh, T. Yamazawa, K. Hirose et al., Novel Mutations in C-terminal Channel Region of the Ryanodine Receptor in Malignant Hyperthermia Patients, The Japanese Journal of Pharmacology, vol.88, issue.2, pp.159-166, 2002.
DOI : 10.1254/jjp.88.159

C. Perez, A. Voss, I. Pessah, and P. Allen, RyR1/RyR3 Chimeras Reveal that Multiple Domains of RyR1 Are Involved in Skeletal-Type E-C Coupling, Biophysical Journal, vol.84, issue.4, pp.2655-2663, 2003.
DOI : 10.1016/S0006-3495(03)75071-1

C. Ponting, Novel repeats in ryanodine and IP3 receptors and protein O-mannosyl-transferases, Trends Biochem Sci, vol.25, pp.48-50, 2000.

K. Quane, J. Healy, K. Keating, B. Manning, F. Couch et al., Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia, Nature Genetics, vol.19, issue.1, pp.51-55, 1993.
DOI : 10.1006/abio.1987.9999

K. Quane, K. Keating, J. Healy, B. Manning, R. Krivosic-horber et al., Mutation Screening of the RYR1 Gene in Malignant Hyperthermia: Detection of a Novel Tyr to Ser Mutation in a Pedigree with Associated Central Cores, Genomics, vol.23, issue.1, pp.236-239, 1994.
DOI : 10.1006/geno.1994.1483

K. Quane, H. Ording, K. Keating, B. Manning, R. Heine et al., Detection of a novel mutation at amino acid position 614 in the ryanodine receptor in malignant hyperthermia, British Journal of Anaesthesia, vol.79, issue.3, pp.332-337, 1997.
DOI : 10.1093/bja/79.3.332

R. Robinson, C. Brooks, S. Brown, F. Ellis, . Halsall et al., RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes, Human Mutation, vol.5, issue.2, pp.88-97, 2002.
DOI : 10.1002/humu.10098

R. Robinson, M. Anetseder, V. Brancadoro, C. Van-broekhoven, A. Carsana et al., Recent advances in the diagnosis of malignant hyperthermia susceptibility: How confident can we be of genetic testing?, European Journal of Human Genetics, vol.11, issue.4, pp.342-348, 2003.
DOI : 10.1038/sj.ejhg.5200964

N. Romero, N. Monnier, L. Viollet, A. Cortey, M. Chevallay et al., Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia, Brain, vol.126, issue.11, pp.2341-2349, 2003.
DOI : 10.1093/brain/awg244

H. Rueffert, D. Olthoff, C. Deutrich, C. Meinecke, and U. Froster, Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations, Acta Anaesthesiologica Scandinavica, vol.52, issue.4, pp.692-698, 2002.
DOI : 10.1097/00000542-199602000-00009

N. Sambuughin, T. Nelson, J. Jankovic, C. Xin, G. Meissner et al., Identification and functional characterization of a novel ryanodine receptor mutation causing malignant hyperthermia in North American and South American families, Neuromuscular Disorders, vol.11, issue.6-7, pp.530-537, 2001.
DOI : 10.1016/S0960-8966(01)00202-4

N. Sambuughin, H. Holley, S. Muldonn, B. Brandom, A. De-bantel et al., Screening of the Entire Ryanodine Receptor Type 1 Coding Region for Sequence Variants Associated with Malignant Hyperthermia Susceptibility in the North American Population, Anesthesiology, vol.102, issue.3, pp.515-521, 2005.
DOI : 10.1097/00000542-200503000-00007

S. Shepherd, F. Ellis, J. Halsall, P. Hopkins, and R. Robinson, RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene, Journal of Medical Genetics, vol.41, issue.3, p.33, 2004.
DOI : 10.1136/jmg.2003.014274

S. Stewart, K. Hogan, H. Rosenberg, and J. Fletcher, Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia, Clinical Genetics, vol.64, issue.Suppl. 1, pp.178-184, 2001.
DOI : 10.1034/j.1399-0004.2001.590306.x

J. Tong, H. Oyamada, N. Demaurex, S. Grinstein, T. Mccarthy et al., Caffeine and Halothane Sensitivity of Intracellular Ca2+ Release Is Altered by 15 Calcium Release Channel (Ryanodine Receptor) Mutations Associated with Malignant Hyperthermia and/or Central Core Disease, Journal of Biological Chemistry, vol.272, issue.42, pp.26332-26339, 1997.
DOI : 10.1074/jbc.272.42.26332

J. Tong, T. Mccarthy, and D. Maclennan, Measurement of Resting Cytosolic Ca2+ Concentrations and Ca2+ Store Size in HEK-293 Cells Transfected with Malignant Hyperthermia or Central Core Disease Mutant Ca2+ Release Channels, Journal of Biological Chemistry, vol.274, issue.2, pp.693-702, 1999.
DOI : 10.1074/jbc.274.2.693

A. Urwyler, T. Deufel, T. Mccarthy, and S. West, Guidelines for molecular genetic detection of susceptibility to malignant hyperthermiadagger, British Journal of Anaesthesia, vol.86, issue.2, pp.283-287, 2002.
DOI : 10.1093/bja/86.2.283

M. Weglinski, D. Wedel, and A. Engel, Malignant Hyperthermia Testing in Patients with Persistently Increased Serum Creatine Kinase Levels, Anesthesia & Analgesia, vol.84, issue.5, pp.1038-1041, 1997.
DOI : 10.1097/00000539-199705000-00016

R. Weiss, O. Connell, K. Flucher, B. Allen, P. Grabner et al., Functional analysis of the R1086 H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling, 2004.

R. Xia, T. Stangler, and J. Abramson, Skeletal Muscle Ryanodine Receptor Is a Redox Sensor with a Well Defined Redox Potential That Is Sensitive to Channel Modulators, Journal of Biological Chemistry, vol.275, issue.47, pp.36556-36561, 2001.
DOI : 10.1074/jbc.M007613200

A. Zable, T. Favero, and J. Abramson, Glutathione Modulates Ryanodine Receptor from Skeletal Muscle Sarcoplasmic Reticulum: EVIDENCE FOR REDOX REGULATION OF THE Ca2+ RELEASE MECHANISM, Journal of Biological Chemistry, vol.272, issue.11, pp.7069-7077, 1997.
DOI : 10.1074/jbc.272.11.7069

Y. Zhang, H. Chen, V. Khanna, D. Leon, S. Phillips et al., A mutation in the human ryanodine receptor gene associated with central core disease, Nature Genetics, vol.28, issue.1, pp.46-51, 1993.
DOI : 10.1006/abio.1987.9999

M. Zhao, P. Li, X. Li, L. Zhang, R. Winkfein et al., Molecular Identification of the Ryanodine Receptor Pore-forming Segment, Journal of Biological Chemistry, vol.274, issue.37, pp.25971-25974, 1999.
DOI : 10.1074/jbc.274.37.25971